TATA Health International Holdings Limited released its Monthly Return for the period ended 31 March 2026, confirming stable capital structure and continued compliance with Hong Kong listing requirements.

• Authorised Capital: Remained at 500.00 million ordinary shares with a par value of HKD 0.01, representing authorised share capital of HKD 5.00 million at month-end.

• Issued Shares: Unchanged at 242.85 million ordinary shares. The company held no treasury shares, resulting in total issued share capital equal to the outstanding share count.

• Capital Movements: The filing recorded no share issuances, repurchases, conversions, or warrant/option exercises during the month. No other corporate actions affecting share capital were reported.

• Public Float: Management confirmed that at least 25% of the company’s issued shares remained in public hands, meeting the Main Board’s minimum float requirement.

The disclosure indicates a steady equity profile for TATA HEALTH through March 2026, with regulatory obligations fully satisfied.